Glenn Muir
REPLIGENAbout Glenn P. Muir
Independent director of Repligen since October 2015; age 66 as of the 2025 annual meeting. Former EVP and CFO of Hologic with 30+ years of finance leadership; CPA (inactive since 2022). Serves as Audit Committee Chair and is designated the Audit Committee financial expert; member of the Compensation Committee (rejoined Feb 2025). Degrees: B.A. University of Massachusetts Amherst, M.S. Taxation Bentley University, MBA Harvard University. Independent under Nasdaq standards.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Hologic, Inc. | Executive Vice President and Chief Financial Officer | 1988–2014; CFO since 1992; EVP since 2000 | Led transformation from venture-backed to diversified public company with ~$2.5B revenue; M&A integration and global finance leadership. |
| Metallon Engineered Materials Co. | Vice President, Finance | 1986–1988 | Finance leadership at private company. |
| Arthur Andersen & Co. | Senior Auditor | 1981–1984 | Public accounting; audit expertise. |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Neuronetics, Inc. (public) | Director | Since July 2017 | Current public board. |
| G1 Therapeutics, Inc. (public) | Director | Oct 2015–Sept 2024 | Prior public board. |
| ReWalk Robotics Ltd. (public) | Director | July 2014–Dec 2017 | Prior public board. |
Board Governance
- Committee assignments: Audit Committee Chair; Compensation Committee member (departed Sept 2024, rejoined Feb 2025). N&CG membership not indicated. Audit Committee met 6 times in FY2024; Compensation Committee met 4 times; N&CG met 2 times.
- Independence and attendance: Board determined all nominees except CEO and Executive Chair are independent; Audit members meet SEC heightened independence and Muir is the “financial expert.” All directors attended 100% of Board and committee meetings in FY2024; in the latest period, one unnamed director missed one of two committee meetings; executive sessions held each meeting.
- Leadership structure: Board led by Executive Chair and Lead Independent Director (separate from CEO), reinforcing independence and oversight.
Fixed Compensation
| Year | Cash Retainer (Board) | Committee Chair Fees | Committee Member Fees | Total Cash Fees |
|---|---|---|---|---|
| 2023 | $60,000 | Audit Chair $30,000 | Compensation Member $10,000 | $105,000 |
| 2024 | $60,000 | Audit Chair $30,000 | Compensation Member $10,000 | $101,667 (proration reflected) |
Notes:
- 2023 Chair add’l retainer applied to Board Chair (not Muir). In 2024, Lead Independent Director retainer ($45,000) applies to Lead Director (not Muir).
Performance Compensation
| Grant Date | Equity Type | Shares/Options | Exercise Price | Grant Date Fair Value | Vesting |
|---|---|---|---|---|---|
| 5/16/2024 | RSU | 701 | — | $119,892 | Vests in full on earlier of 1st anniversary or next annual meeting. |
| 5/16/2024 | Stock Options | 1,376 | $171.03 | $116,759 | Same vest schedule; options become 100% vested upon sale event. |
Additional policy:
- Annual director equity set at $240,000 for non-chair in 2024 (50% RSUs, 50% options); sale event acceleration applies.
Other Directorships & Interlocks
| Counterparty | Overlap/Link | Potential Relevance |
|---|---|---|
| Hologic, Inc. | Muir is former CFO; another RGEN director (Martin D. Madaus) currently serves on Hologic’s board | Network ties; no disclosed related-party transactions or conflicts. |
Expertise & Qualifications
- Finance and capital markets; audit and controls; M&A integration; manufacturing/commercial operations insights from Hologic tenure; CPA (inactive).
Equity Ownership
| Holder | Shares Beneficially Owned | % of Class | Components within 60 days |
|---|---|---|---|
| Glenn P. Muir | 48,016 | * | Includes 16,434 options exercisable within 60 days. |
Stock ownership guidelines:
- Directors must hold 4x annual cash retainer; restricted stock/RSUs count, options/PSUs do not; all directors comply or are on track. Anti-hedging/pledging policies in place (pre-approval required for certain transactions).
Governance Assessment
- Strengths: Independent status; Audit Chair and SEC-designated financial expert; robust attendance; clear anti-hedging/pledging and ownership guidelines; no related-party transactions >$120,000; active shareholder engagement; clawback policy compliant with SEC/Nasdaq.
- Pay-structure alignment: Director cash fees steady; equity retainer increased in 2024 following consultant review, maintaining 50/50 RSU/option mix that vests on annual cycle—moderate at-risk exposure via option component.
- RED FLAGS: None disclosed for Muir—no attendance shortfall, no hedging/pledging disclosed, no related-party transactions, no Section 16 delinquency noted for him.
Context signals for investor confidence: Audit Committee met 6 times in FY2024 with Muir as Chair; he signed the Audit Committee Report, reinforcing oversight credibility. Say-on-pay support ~94% in 2024 (prior year 97%) indicates positive shareholder sentiment toward compensation governance.